A. “CCL2 Is Associated with a Faster Rate of Cognitive Decline during Early Stages of Alzheimer’s Disease,” by Karin Westin, Peder Buchhave, Henrietta Nielsen, Lennart Minthon, Sabina Janciauskiene, and Oskar Hansson (PLoS ONE 7(1): e30525. doi:10.1371/journal.pone.0030525, XML, HTML, and .pdf format, 6p.).
www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0030525
B. “LRRK2 Phosphorylates Tubulin-Associated Tau but Not the Free Molecule: LRRK2-Mediated Regulation of the Tau-Tubulin Association and Neurite Outgrowth,” by Fumitaka Kawakami, Takatoshi Yabata, Etsuro Ohta, Tatsunori Maekawa, Naoki Shimada, Minori Suzuki, Hiroko Maruyama, Takafumi Ichikawa, and Fumiya Obata (PLoS ONE 7(1): e30834. doi:10.1371/journal.pone.0030834, XML, HTML, and .pdf format, 9p.).
www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0030834
